← Back
$AVDL All transactions

AVADEL PHARMACEUTICALS PLC

G

$ Value

$0

Shares

67,025

Price

$0

Filed

Feb 6

Insider

Name

McCamish Mark Anthony

Title

CIK

0001390798

Roles

Director

Transaction Details

Transaction Date

2026-02-04

Code

G

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

67,025

Footnotes

On February 4, 2026, the Reporting Person transferred 67,025 shares from Matthew 5 LLC to the McCamish Charitable Remainder Trust. | Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager. | Shares held by McCamish Charitable Remainder Trust, of which the Reporting Person and his spouse are income beneficiaries. The Reporting Person disclaims beneficial ownership except to the extent of his and his spouse's pecuniary interest therein.

Filing Info

Accession No.

0001104659-26-011511

Form Type

4

Issuer CIK

0001012477

McCamish Mark Anthony's History

Date Ticker Type Value
2026-02-12 AVDL D $462K
2026-02-12 AVDL D $1.4M
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D
2026-02-12 AVDL D

Other Insiders at AVDL (90d)

Insider Bought Sold Last
MCHUGH THOMAS S
Chief Financial Officer
2026-02-12
Thornton Peter J. 2026-02-12
Weiss Asset Management LP $233.4M 2026-02-13
McCamish Mark Anthony 2026-02-12
Divis Gregory J
Chief Executive Officer
2026-02-12
Ende Eric J 2026-02-12
Glass Geoffrey Michael 2026-02-12
Amin Naseem 2026-02-12
Palczuk Linda 2026-02-12
Rodriguez Susan
Chief Operating Officer
2026-02-12
Seurer Jerad G.
Gen. Counsel & Corp. Secretary
2026-02-12